Key Insights

Highlights

Treatment Research

4 treatments under study, led by Gemcitabine Platinum Based Chemotherapy Cisplatin Or Carboplatin

Related Conditions

Often studied with 14 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07869836Phase 3Recruiting

BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy

NCT05207969Not ApplicableUnknown

Efficacy of the Act of Urination to Relief the Pain During Flexible Cystoscopy Procedure.

Showing all 2 trials

Research Network

Common Treatments

  • Gemcitabine Platinum Based Chemotherapy Cisplatin Or Carboplatin1
  • Tbren Dose Level 21
  • Tbren Dose Level 11
  • Instruction To Urinate1

Active Sponsors

  • SystImmune Inc.1
  • Universiti Sains Malaysia1

Top Investigators

Related Conditions

  • Urothelial Carcinoma Bladder1
  • Urothelial Carcinoma Recurrent1
  • Urothelial Cancer1
  • Urothelial Carcinoma Of The Urinary Bladder1
  • Bladder Cancer1

Activity Timeline